GLP-1 Receptor Agonist
Ozempic®(Semaglutide)
The Original Semaglutide That Started It All
Ozempic® (semaglutide) is FDA-approved for type 2 diabetes and widely prescribed for weight loss. The medication that sparked the GLP-1 weight loss revolution.
Avg weight loss
14-15%
vs retail
82%
up to 82% savings vs ~$950/mo retail
Frequency
Once Weekly
Most patients start at $275/mo. Some starting options are as low as $149/mo. Final pricing is set with your provider during your consultation.
How Ozempic works
Ozempic contains semaglutide, which mimics your body's natural GLP-1 hormone. It reduces appetite by acting on hunger centers in the brain, slows stomach emptying so you feel full longer, and improves blood sugar control. This triple action makes it highly effective for both diabetes and weight loss.
Clinical evidence: In the SUSTAIN trials, patients taking the highest Ozempic dose (2mg) lost an average of 14-15% of their body weight as a secondary benefit while treating diabetes.
Benefits at PWL
- Well-established safety and efficacy profile
- Significant 14-15% average weight loss
- Excellent blood sugar control for diabetics
- Once-weekly injection convenience
- Cardiovascular protection
- Most affordable GLP-1 option
- Years of real-world usage data
- Often available when newer medications face shortages
Common side effects
- Nausea (usually mild and temporary)
- Vomiting or diarrhea
- Constipation
- Abdominal pain
- Injection site reactions
Side effects are typically mild and improve over time. Your provider will guide you on managing any symptoms during your monthly check-ins.